Truist Securities Maintains Hold on Zimmer Biomet Holdings, Lowers Price Target to $130
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Richard Newitter maintains a Hold rating on Zimmer Biomet Holdings (ZBH) and lowers the price target from $137 to $130.
May 03, 2024 | 2:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Truist Securities maintains a Hold rating on Zimmer Biomet Holdings and lowers the price target from $137 to $130.
The reduction in the price target by Truist Securities suggests a less optimistic outlook on Zimmer Biomet Holdings' future stock performance, potentially leading to a negative short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100